Cell Mol Life Sci 2009,66(4):613–635 PubMedCrossRef 2 Rivera J,

Cell Mol Life Sci 2009,66(4):613–635.PubMedCrossRef 2. Rivera J, Vannakambadi G, Höök M, Speziale P: Fibrinogen-binding proteins of Gram-positive bacteria. Thromb Haemost 2007,98(3):503–511.PubMed 3. Speziale P, Pietrocola G, Rindi S, Provenzano M, Provenza G, Di Poto A, Visai L, Arciola CR: Structural

and RG-7388 ic50 functional role of Staphylococcus aureus surface components recognizing adhesive matrix molecules of the host. Future Microbiol 2009, 4:1337–1352.PubMedCrossRef 4. Cegelski L, Marshall GR, Eldridge GR, Hultgren SJ: The biology and future prospects of antivirulence therapies. Nat Rev Microbiol 2008,6(1):17–27.PubMedCrossRef 5. Adavosertib datasheet Rasko DA, Sperandio V: Anti-virulence strategies to combat bacteria-mediated disease. Nat Rev Drug Discov 2010,9(2):117–128.PubMedCrossRef 6. Niemann HH, Schubert WD, Heinz DW: Adhesins and invasins of pathogenic bacteria: a structural view. Microbes Infect 2004,6(1):101–112.PubMedCrossRef 7. Paschke M: Phage display systems and their applications. Appl Microbiol Biotechnol 2006,70(1):2–11.PubMedCrossRef 8. Samuelson P, Gunneriusson E, Nygren P, Ståhl S: Display of proteins on bacteria. J Biotechnol 2002,96(2):129–154.PubMedCrossRef 9. Majander K, Anton L, Kylväjä R, Westerlund-Wikström B: The bacterial flagellum as a surface display and expression tool. In Pili and flagella: Current research and future trends. Edited by: Jarrell KF. Norfolk UK: Caister Academic Press; 2009:191–206. 10.

Yan X, Xu Z: Ribosome-display technology: applications for directed evolution of mTOR inhibitor functional proteins. Drug Discov Today 2006,11(19–20):911–916.PubMedCrossRef 11. Choi JH, Lee SY: Secretory and extracellular production of recombinant proteins

using Escherichia coli . Appl Microbiol Biotechnol 2004,64(5):625–635.PubMedCrossRef 12. Ni Y, Chen R: Extracellular recombinant protein production ID-8 from Escherichia coli . Biotechnol Lett 2009,31(11):1661–1670.PubMedCrossRef 13. Clarke SR, Foster SJ: Surface adhesins of Staphylococcus aureus . Adv Microb Physiol 2006, 51:187–224.PubMedCrossRef 14. Foster TJ, Höök M: Surface protein adhesins of Staphylococcus aureus . Trends Microbiol 1998,6(12):484–488.PubMedCrossRef 15. Chavakis T, Wiechmann K, Preissner KT, Herrmann M: Staphylococcus aureus interactions with the endothelium: the role of bacterial “”secretable expanded repertoire adhesive molecules”" (SERAM) in disturbing host defense systems. Thromb Haemost 2005,94(2):278–285.PubMed 16. Barbu EM, Ganesh VK, Gurusiddappa S, Mackenzie RC, Foster TJ, Sudhof TC, Höök M: beta-Neurexin is a ligand for the Staphylococcus aureus MSCRAMM SdrC. PLoS Pathog 2010,6(1):e1000726..PubMedCrossRef 17. Clarke SR, Brummell KJ, Horsburgh MJ, McDowell PW, Mohamad SA, Stapleton MR, Acevedo J, Read RC, Day NP, Peacock SJ, Mond JJ, Kokai-Kun JF, Foster SJ: Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage. J Infect Dis 2006,193(8):1098–1108.PubMedCrossRef 18.

Comments are closed.